Speakers
Yang-Soo Jang
Republic of Korea, Chair of
Healthcare Review and Assessment
Committee of HIRA
Jae-Lyun Lee
Republic of Korea, Professor of Department of Oncology of Asan Medical Center
Jung-Shin Lee
Republic of Korea, Chair of Pharmaceutical Reimbursement Evaluation Committee of HIRA
Speakers
Yang-Soo Jang
Republic of Korea, Chair of Healthcare Review and Assessment Committee of HIRA
Jae-Lyun Lee
Republic of Korea, Professor of Department of Oncology of Asan Medical Center
Jung-Shin Lee
Republic of Korea, Chair of Pharmaceutical Reimbursement Evaluation Committee of HIRA
Health Insurance Review and Assessment Service(HIRA)
60 HYEOKSIN-RO, WONJU-SI, GANGWON-STATE(BANGOK-DONG) 26465, KOREA / TEL. +82-2-1644-2000
Agency Connectus Co., Ltd.
29 DONGMAK-RO, MAPO-GU, SEOUL, KOREA
Health Insurance Review and Assessment Service(HIRA)
60 HYEOKSIN-RO, WONJU-SI, GANGWON-STATE(BANGOK-DONG) 26465, KOREA / TEL. +82-2-1644-2000
Agency Connectus Co., Ltd.
29 DONGMAK-RO, MAPO-GU, SEOUL, KOREA
David A. Simon
[Experience]
・ Professor of Northeastern University School of Law, USA
・ Co-Director of Amy J. Reed Collaborative for Medical Device Safety, USA
・ Assistant Professor of the George Washington University Law School, USA
・ Research Fellow & Lecturer on Law of the Harvard Law School, USA
[Education]
・ PhD in University of Cambridge, UK (2019)
・ LLM in Harvard Law School, USA (2010)
・ JD in Chicago-Kent College of Law, USA (2008)
・ BA in University of Michigan, USA (2005)
Andrzei Orlowski
[Experience]
・ Director, Health Economics Unit (HEU), NHS, UK (Oct 2020 – Present)
・ Senior Advisor, NHS England (PHM & New Care Models), UK (Oct 2016 – Present)
・ Senior Advisor, World Bank Group, UK (Sep 2018 – Present)
・ Lecturer, Imperial College London, UK (Sep 2020 – Present)
・ President, Association of Professional Healthcare Analysts (AphA), UK (Oct 2020 – Present; President since Jan 2022)
・ Vice-Chair, Healthcare Value Institute, UK (May 2021 – Present; Vice-Chair since Oct 2023)
・ Deputy Director of Business Intelligence, Imperial College Health Partners, UK (2016–2020)
・ Associate Director – Health & Implementation, Greater Manchester AHSN, UK (2014–2017)
・ Interim Consultant, NHS and public sector roles, UK (2008–2016)
・ Brand Director at Takeda and Brand Team Leader at Roche, UK (1999–2008)
[Education]
・ PhD in Medical Statistics in Imperial College London, UK (in progress; expected 2026)
・ MSc in Health Economics, Policy and Management in London School of Economics, UK (2016–2019)
・ BSc (Hons) in Marketing and Pharmacology in University of East London, UK (1992–1996)
Andrea Parziale
[Experience]
・ Professor of Comparative Law of Sant’Anna School of Advanced Studies, Italy (Present)
・ Assistant Professor of Health Law of Department of Health, Ethics and Society of Faculty of Health, Medicine and Life Sciences of Maastricht University, Netherlands (Sep 2023 – Aug 2024)
・ Postdoctoral Research Fellow of International Law Department of Faculty of Law of Maastricht University, Netherlands (Apr 2022 – Aug 2023)
・ Postdoctoral Research Fellow, Institute for Biomedicine, EURAC Research, Italy (2021 – 2022)
[Education]
・ PhD in Law with highest honors in Sant’Anna School of Advanced Studies, Italy (2019)
Hisashi Urushihara
[Experience]
・ Professor of Division of Drug Development and Regulatory Science of Keio University School of Pharmacy, Japan (2016 – Present)
・ President of Japanese Society for Pharmacoepidemiology, Japan (Present)
・ Associate Professor of Division of Drug Development and Regulatory Science of Keio University School of Pharmacy, Japan (2013 – 2016)
・ Lecturer of Committee of Medical Ethics, Kyoto University School of Medicine and Public Health, Japan (2012 – 2013)
・ Assistant Professor of Division of Pharmacoepidemiology of Kyoto University School of Public Health, Japan (2008 – 2012)
・ Clinical Development and Pharmacovigilance of Eli Lilly Japan, Japan (1995 – 2015)
[Education]
・ PhD in Clinical Epidemiology in Kyoto University School of Public Health, Japan (2008)
Wei-I Huang
[Experience]
・ Director of Taiwan National ADR Reporting Center, Taiwan (Present)
・ Director of Drug Safety Division of ADR Reporting Center, Taiwan (Present)
・ Board Director of Taiwan Society for Pharmacoeconomics and Outcome Research (TaSPOR), Taiwan (Present)
・ Member of Communicable Disease Control Advisory Committee, Ministry of Health and Welfare, Taiwan (Present)
[Education]
・ MSc in Clinical Pharmacy in School of Pharmacy of Taipei Medical University, Taiwan
Jae-Lyun Lee
[Experience]
・ Professor of Division of Oncology of Asan Medical Center, Republic of Korea (Present)
・ Professor of Department of Internal Medicine of University of Ulsan College of Medicine, Republic of Korea (Present)
・ Chair of Insurance Policy Committee of Korean Society of Medical Oncology (KSMO), Republic of Korea (Present)
・ Former Chair of Genitourinary Oncology Committee of Korean Cancer Study Group (KCSG), Republic of Korea/p>
[Education]
・ PhD in Oncology in University of Ulsan College of Medicine, Republic of Korea
・ MSc in Internal Medicine in Yeungnam University College of Medicine, Republic of Korea
Jung-Shin Lee
[Experience]
・ Chair of Pharmaceutical Reimbursement Evaluation Committee of HIRA, Republic of Korea
・ Emeritus Professor of Ulsan University, Republic of Korea
・ President of Asan Medical Center, Republic of Korea
・ President of Korean Cancer Association, Republic of Korea
[Education]
・ PhD in Medicine in Kyung Hee University College of Medicine, Republic of Korea